The incidence and significance of multiple lesions in glioblastoma.
The location and distribution of glioblastoma (GBM) within the brain parenchyma plays an important role in surgical and radiation planning. Prior studies have reported incidences of multiple lesions at the time of diagnosis ranging from 0.5 to 20 %. Multiple lesions can be further categorized as multifocal (multiple areas involved, but with a clear path of spread from one lesion to another) or multicentric (multiple lesions, no clear path of spread). In this retrospective study, we reviewed our experience with GBM and found the incidence of multiple lesions at time of diagnosis was 35 %, much higher than previously suggested in the literature. Patients with single lesions had an improved overall survival when compared to patients with multiple lesions (18 vs. 10 months). Patients with multicentric lesions fared the worst, with average survival of 3 months. However, the difference between single and multiple lesions (multifocal or multicentric) was no longer significant when taking into consideration age, Karnofsky performance score (KPS) and extent of resection by multivariate analysis. Age, KPS, gross total resection, and MGMT status were independent predictors of outcome. Multiple lesions did not independently confer a worse outcome, but were associated with lower KPS scores and inability to perform gross total resection. These findings suggest that single, multiple and multicentric imaging exams represent a spectrum of presentations of a single disease. The rate of multiple lesions reported here may be the result of improved imaging technology, suggesting that incidence of multiple lesions will continue to increase as imaging technology advances.
Department of Neurology, Stanford University Hospital, 300 Pasteur Drive, Room A343, Palo Alto, CA 94304-5235, USA. Reenat@stanford.edu
Reena P
RP
Thomas
Linda W
LW
Xu
Robert M
RM
Lober
Gordon
G
Li
Seema
S
Nagpal
D001921:Brain / Q000473:pathology*; D001932:Brain Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology*; D005260:Female; D005909:Glioblastoma / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology*; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D017567:Karnofsky Performance Status; D008279:Magnetic Resonance Imaging; D008297:Male